OmniaBio

OmniaBio is a Canadian contract development and manufacturing organization (CDMO) that specializes in cell and gene therapy. Established on July 1, 2022, as a subsidiary of CCRM, the company is dedicated to advancing life-saving therapies by offering a full range of services from early process development to commercial-scale manufacturing. The company provides services such as process development, analytical development, and GMP manufacturing, ensuring compliance for clinical and commercial supply. OmniaBio has expertise in both autologous and allogeneic manufacturing and utilizes advanced technologies, including artificial intelligence and robotics, to create efficient manufacturing processes. With a focus on personalized client services, OmniaBio supports its partners with dedicated project management and real-time data sharing. Headquartered in Hamilton, Ontario, OmniaBio serves a global customer base, including clinical-stage biopharmaceutical companies and research organizations. The company collaborates with various partners to develop innovative therapies, aiming to enhance the affordability and accessibility of transformative treatments worldwide.

Pharmaceuticals Hamilton, Canada ~135 employees

Work at OmniaBio in HR or recruiting? Claim this page

Employees
135
+7.1% in the 3 months to Jun 2025
Total funding
$90M
Last round May 2022
12-month attrition
11%
Tech: 16.7%
H1B sponsor
NA

Headcount trend

OmniaBio went from 55 employees in Jul 2023 to 135 in Jun 2025. Jan to Jun 2025: 34 people joined, 7 left.

Headcount data through Jun 2025

Funding rounds

Total funding$90M
Funding rounds1
Investors1
DateRoundMoney raisedNo.Investors
May 2022Funding$90M1

Org structure

Headcount by department

Other95
Operations18
Sales9
Finance3
HR3
Engineering3
Success3
Marketing1

OmniaBio FAQ

How many employees does OmniaBio have?

OmniaBio has about 135 employees, up 7.1% over the 3 months to Jun 2025.

How much funding has OmniaBio raised?

OmniaBio has raised $90M in total funding.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.